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Abstract
Keratoconus is a disease characterized by progressive thinning, bulging, and distortion of the cornea. Advanced
cases usually present with loss of vision due to high irregular astigmatism. A majority of these cases require surgical
intervention. This review provides an update on the current treatment modalities of corneal surgery available for
the management of advanced corneal ectasias.
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Background
Corneal graft is the traditional recourse for advanced
keratoconus [1]. There are many different grading
schemes for keratoconus from scales based on outdated
indices such as the Amsler-Krumeich scale, to scales
using a variety of detailed metrics of corneal structure
provided by anterior segment optical coherence tomog-
raphy and Pentacam imaging. All these different scales
do not always correlate well with disease impact.
While there are eyes with milder disease that may ex-
hibit contact lens intolerances, there are other eyes
with severe disease that obtain good functional vision
with contact lenses.
Therefore, although there is no precise definition for
advanced disease, most specialists would agree that a
keratoconus patient is eligible for corneal transplant
when spectacle correction is insufficient, continued con-
tact lens wear is intolerable, and visual acuity has fallen
to unacceptable levels [2]. Nevertheless, there has been a
strong push to extend other treatment modalities that
were originally meant for mild to moderate disease such
as ultraviolet crosslinking (UV-CXL) and intrastromal
corneal ring segments (ICRS) to treat advanced disease.
In 2014, Bowman Layer transplantation was also de-
scribed for advanced keratoconus with extreme thin-
ning/steepening [3]. These less troublesome therapeutic
alternatives will seek to arrest disease progression, re-
enable comfortable contact lens, or improve visual acuity
to some extent, although rarely do the visual gains
exceed one or two lines in advanced disease. These tech-
niques would permit penetrating keratoplasty (PK) or
deep anterior lamellar keratoplasty (DALK) to be post-
poned or avoided entirely [2].
In general, despite the excellent outcomes of PK,
DALK may be preferred in patients with keratoconus
because of the absence of risk of endothelial rejection,
earlier tapering of steroids, decreased risk of secondary
glaucoma, and increased wound strength [4]. The advan-
tage of DALK is even more evident in patients with
mental retardation in which PK has a higher incidence
of postoperative complications such as globe rupture,
corneal ulceration and graft rejection, as well as in
phakic patients, and corneas with significant peripheral
thinning [2].
PK would be considered more suitable in cases where
endothelial dysfunction is present or when deep corneal
scarring severely affects the visual axis up to the Desce-
met membrane (DM) level. It is not unusual for kerato-
conus to coexist with endothelial dysfunction; it might
be underestimated as stromal thinning of keratoconus
may mask the corneal edema. Fuchs endothelial dys-
trophy is the most common of such disorders, but also
include posterior polymorphous dystrophy, a peculiar
condition of endothelial depletion and guttae excres-
cences that may be the product of the keratoconus itself
rather than a distinct entity [5]. If central deep corneal
scarring is present, PK will provide a better visual acuity
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than DALK, but with a higher risk. In some instances,
safety of DALK can outbalance the better visual acuity
of PK. In fact, when corneal scars arise from previous
hydrops, PK outcomes tend to be worse as the risk of
graft rejection is higher [2]. In these cases, manual la-
mellar dissection for DALK is a good choice as Anwar’s
big bubble technique is contraindicated owing to the
high risk of perforation during surgery.
While the scope of this article is mainly corneal graft-
ing as treatment of keratoconus, it is important to point
out that the main goal of treatment for keratoconus has
changed over the last few years from that aiming to
improve visual acuity with keratoplasty to a number of
relatively new procedures focused on the prevention of
disease progression or to restore/support contact lens
tolerance by making wearing more comfortable. These
include UV-CXL, ICRS, and a newly proposed type of
“corneal transplant” known as Bowman Layer trans-
plantation described by Gerrit Melles [3]. In Fig. 1, we
present our decision tree for intervention at presentation
in keratoconus.
Review
A review of the literature on the topic of surgical treat-
ment of keratoconus has received considerable attention
and a formidable number and variety of surgical proce-
dures even before keratoplasty was considered the most
suitable procedure [6]. Surgical options that have been
proposed include intraocular operations such as para-
centesis of the anterior chamber, lens extraction or
needling, or deviation of the pupil by incarcerating the
iris in a corneal incision to achieve a stenopeic slit-like
pupil; cone excision procedures; or flattening techniques
by scar formation, brought by cauterization of the conus
with chemicals, electrocautery, high frequency current
or by splitting the DM [6].
Before keratoplasty became an option, Alfred
Appelbaum in 1936 [7] stated concerning the surgi-
cal treatment of keratoconus, “Surgical intervention
aims to produce flattening of the cornea in order to
improve eyesight. When no degree of useful vision is
obtained with the use of contact glasses, operative
intervention may be considered – but no sooner.
Only in cases of advanced or nearly hopeless condi-
tions should the patient undergo operation. Most
ophthalmologists agree with this. Too much cannot
be expected of surgical treatment. At best, it gives a
result far from ideal and none too lasting. The un-
sightliness which inevitably follows must be antici-
pated, and the appearance of the eye is always
marred to some extent.”
Castroviejo, a Spanish ophthalmologist born in
Logroño, Spain, performed the first PK for keratoconus
in 1936 [6] in the Columbia Presbyterian Medical Center
in New York. Several years later in an article about
keratoplasty for the treatment of keratoconus, he con-
cluded that keratoplasty was the only surgical procedure
that fulfilled the two essential requirements for treating
keratoconus: surgery had to be limited to the cornea,
and the whole corneal protrusion had to be removed
and replaced with normal tissue of normal curvature
and thickness, leaving the pupillary area free of scarring.
Fig. 1 Decision tree for intervention at presentation in keratoconus. Grading according to the RETICS classification [1]. (* if thinnest point >
370 μm; ** wavefront guided transPRK (limited treatment) to reduce coma-like aberrations and increase CDVA; *** if corneal scarring, insufficient
corneal thickness for ICRS implantation or ICRS failure with persistent contact/scleral lenses intolerance and poor CDVA)
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Based on his experience, when a suitable technique was
used, the percentage of permanently, greatly improved
vision increased from 75 % to 90 % [6].
Lamellar keratoplasty (LK) was described earlier than
PK. Although Arthur von Hippel performed the first
successful LK in man in 1888 [8] decades earlier than
the first successful human PK by Edward Zinn, Von
Hippel’s technique was abandoned in 1914 for PK and
was not reintroduced until the 1940s [9]. However, the
concept of deep LK extending down to DM is relatively
new. Gasset reported a series of keratoconus patients in
the late 1970s who received full-thickness grafts stripped
of DM transplanted into relatively deep lamellar beds,
and enjoyed good surgical results with 80 % of cases
achieving 20/30 or better vision [10]. Dissection of host
tissue ‘close to’ DM and the term ‘deep lamellar kerato-
plasty’ (DLK) in the conventional sense were first intro-
duced by Archilla in 1984, who also showed the use of
intrastromal air injection to opacify the cornea as a
method to facilitate removal of host tissue [11]. Sugita
and Kondo reported the first extensive study on the re-
sults of DLK compared with PK in 1997 [12]. They
showed that postoperative visual acuity was similar be-
tween DLK and PK with no episodes of immunological
rejection in over 100 eyes. Despite the clear benefits of
DLK, the classical technique of removing stroma layer
by layer was at that stage time-consuming and was
greatly dependent on surgical experience. Only in the
last two decades did DLK gain momentum thanks to im-
provement in surgical techniques and the availability of
new surgical instruments and devices. The two most
relevant papers on techniques were those from Melles
and Anwar.
In 1999, Melles described a technique to visualize
corneal thickness and dissection depth during surgery,
which created an optical interface at the posterior cor-
neal surface by filling the anterior chamber with air
completely [13]. In 2002, Anwar described his popular
“big-bubble” technique in baring DM by injecting air
into the deep stroma to create a large bubble between
the stroma and DM [14].
Approximately about 12–20 % of the keratoconus
patients may require a corneal transplantation [15]. The
Australian Graft Report of 2012 shows that keratoconus,
with almost 1/3 of the corneal grafts performed, was the
first reason for keratoplasty, followed by bullous kerato-
plasty and failed previous grafts. The 2012 Eye Banking
statistical Report published by the Eye Banking Associa-
tions of America found that keratoconus was the reason
for PK in 18 % of the cases and in 40 % of the DALK
cases. Surprisingly, PK represented almost 80 % of the
total grafts while DALK only accounted for 3 % of the
total keratoplasties done, meaning that time-consuming
and surgical experience is still a factor reducing the
popularity of DALK in the US. Increasingly, however,
DALK is becoming the preferred surgical option, largely
thanks to improvements in operative technique, and
now representing 10–20 % of all transplants for kerato-
conus and 30 % when eyes with previous hydrops are ex-
cluded [2]. In the UK, the percentage of transplants for
keratoconus in which DALK was used increased from
10 % in 1999–2000 to 35 % in 2007–2008 [16].
Penetrating keratoplasty in keratoconus
PK has traditionally been the surgery of choice for kera-
toconus, but nowadays lamellar techniques are the gold
standard for patients with mild to moderate disease.
Currently, an elective PK is reserved for those advanced
cases where the DM and endothelium appear splitted
due to a previous corneal hydrops. Frequently, a previ-
ous hydrops is not clearly reported by the patient, but in
absence of an obvious endothelial split, deep stromal
scars involving the DM are observed. In such cases a
lamellar technique can still be attempted, mainly if these
scars are not affecting the visual axis, but as the integrity
of the DM is not intact any longer, this layer has a great
tendency to rupture through the area of the scar (if and
when a Big Bubble technique is used) and the surgery
will need to be converted into a PK intraoperatively if a
big tear is observed (longer than 2 to 3 clock hours).
PK technique for keratoconus does not differ signifi-
cantly from the technique used for other etiologies, but
some considerations should be taken into account:
1. Donor size:
A 7.5–8.5 mm host trephine (in relation with the cor-
neal horizontal diameter) is often used and centered
with the optical axis. However, the cone in keratoconus
is often inferiorly displaced and should be fully removed
to avoid residual or recurrent disease [17]. Therefore,
the extent of the cone should be well understood before
surgery and thinning mapped out by slit lamp examin-
ation, as this will be difficult to discern with the operat-
ing microscope. Fleischer iron ring formation, which
usually circumscribes the cone, may assist on its delinea-
tion. Corneal topography is not reliable in advanced
scarred conus and should not be considered for surgical
planning. Donor size will then be adjusted in relation
with the host limbal white-to-white measurement and
conus extension, so grafts larger than 8.5 mm may occa-
sionally be needed in severe conus, as well as partial
decentration respecting the optical axis in cases of very
advanced conus with a severe thinning up to the peri-
limbal area. Yet, the risk of rejection increases with
grafts larger than 8.5 mm in diameter and when the
graft-host junction moves closer to the limbus, both of
these which should be considered during post-operative
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treatment and management [18, 19]. Decentered grafts
can as well induce a significant irregular astigmatism
into the visual axis that requires rigid lenses for visual
rehabilitation of the patient and occasionally, a second
centered graft for visual purposes.
The donor tissue trephine is routinely sized at
0.25 mm larger than the host trephine because, using
current techniques, donor corneal tissue cut with a tre-
phine from the endothelial surface measures approxi-
mately 0.25 mm less in diameter than host corneal
tissue cut with the same diameter trephine from the epi-
thelial surface [20]. Keratoconus patients may benefit
from using same-diameter trephines for both donor and
host tissues, which undersize the donor button and helps
to reduce postoperative myopia [21, 22], but the surgeon
should be aware that obtaining watertight wound closure
with an undersized donor tissue can be challenging and
may require additional sutures. Moreover, a flattened
corneal contour could complicate contact lens fitting in
the anisometropic patient. Laser excimer ablation for
correction of a significant residual hyperopia after PK
may also not be possible as it is not as predictable and
efficient as it is with residual myopia, which will require
phakic or pseudophakic piggyback intraocular lenses for
patients who are intolerant of spectacles and contact
lenses [23]. Considering the above, although undersizing
the donor cornea may provide better visual outcome in
patients with keratoconus, it should be selected carefully
in PK. Axial length can be an important factor in the
refractive error outcome following PK [24]. Ultrasound
axial length measured from the anterior lens capsule to
retina reveals a broad range in length from 18.77 to
25.65 mm. Reducing donor size, in a relatively short eye,
could result in significant postoperative hyperopia, so
same-size donor and host corneal buttons should not be
used when the anterior lens-to-retina length is less than
20.19 mm, the mean length for non-keratoconic individ-
uals with emmetropia.
2. Suturing technique:
Once the four cardinal 10-0 nylon sutures have been
placed, the surgeon can use any of these preferred suture
techniques: interrupted sutures (IS), combined continu-
ous and interrupted sutures (CCIS), single continuous
suture (SCS) or double continuous suture (DCS). IS
should always be the closure method of choice in cases
where a partial or complete suture removal in one
region of the graft is likely to be necessary at some point
during the postoperative period, examples include:
pediatric keratoplasty (sutures becoming loose too
quickly), vascularization in the host cornea (occasionally
seen after a hydrops episode or contact lens related kera-
titis), multiple previous rejections or other inflammatory
concomitant conditions that may predispose to localized
vascularization, rejection, or ulceration of the donor
tissue. Furthermore, large and decentered grafts that
are placed close to the limbal area present an in-
creased risk of rejection, thus making the use of IS
necessary for its closure.
However, most of the keratoconic eyes do not present
any additional risk for graft rejection or infection, so a
SCS or DCS is generally preferred by most surgeons. The
advantages of a continuous suture are ease of placement,
the ease with which the suture can be removed at a later
date, and the potential for suture adjustment intrasurgi-
cally (with an intraoperative keratometer) and postopera-
tively to reduce astigmatism. With DCS, a 12-bite 10-0
nylon suture placed with bites at approximately 90 %
depth and a second continuous suture (10-0 or 11-0
nylon) placed with bites alternating between each of the
original suture’s bites for 360° at approximately 50–60 %
corneal depth are used. The second suture is tied only
with enough tension to take up slack in the suture. The
second suture permits early removal or adjustment of the
first 10-0 nylon suture for astigmatism control in 2–
3 months; the second suture acts as a safety net if the deep
suture breaks during the adjustment, and is generally left
in place for 12–18 months postoperatively (Fig. 2).
IS, CCIS, and SCS have shown comparable postopera-
tive astigmatism [25]. In addition, a comparison of astig-
matism in keratoconus patients utilizing a single
continuous versus a DCS showed that after suture re-
moval, astigmatism between the two groups was com-
parable (DCS − 4.6 D, SCS − 5.2 D) [26]. Therefore, it is
apparent that all methods of suture closure can work
well. The ultimate choice rests with the surgeon.
Fig. 2 Slit-lamp image of a keratoconic eye after penetrating
keratoplasty with a double continuous suture
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Regardless of the preferred method, it is very import-
ant to have a clear concept of each suture technique. To
give a basic idea for standard graft suturing, the needle
is passed 90 % depth through the donor cornea and then
through the host cornea. The ideal bite is as close to
DM as possible, and there should be an equal
amount of tissue purchased in the donor and host
cornea in order to approximate Bowman’s layer in
both the donor and host. Discrepancies frequently
exist in the thickness of the donor and host corneas
either when donor corneas are thick due to the
hyperosmolar glycosaminoglycans in the preservation
medium or fresh donor tissue is used in patients
with severe corneal edema. This scenario is frequent
in keratoconic eyes where the graft is sutured to a
relatively thin host cornea. Closing Bowman’s layer
to Bowman’s layer should always be attempted to
avoid steps in the graft-host junction and subsequent
exposed sutures. Therefore, in areas where the re-
cipient cornea presents thin (assessed preoperatively
by slit lamp examination) partial thickness bites (50–
70 % depth) in the donor tissue should be in rela-
tion with deep bites (95 % depth) in the host thin
stroma (Fig. 3).
The postoperative astigmatism management and elect-
ive suture adjustment/removal for PK in cases of
previous keratoconus do not differ from other PK indi-
cations. A complete suture removal is generally recom-
mended after 12–15 months.
3. Outcomes:
PK offers good long-term visual rehabilitation for kera-
toconus patients. Compared with other indications for
PK, there is a relatively low rate of graft failure and long
mean graft survival. Rejection rate has been reported to
be 5.8–41 % with a long term follow-up with most rejec-
tions occurring in the first 2 years [27–31]. Larger host
trephine size, male donor gender, and non-white donor
race have been associated with increased rejection haz-
ard [27]. Despite this observed rejection rate, only a 4–
6.3 % graft failure rate has been reported with a mean
follow-up of 15 years, and with an estimated 20 year
probability of 12 % [27, 28, 32]. Fukoka et al. reported a
cumulative probability of graft survival at 10, 20, and
25 years after PK of 98.8, 97.0 and 93.2 %, respectively,
while Pramanik et al. estimated a graft survival rate of
85.4 % at 25 years after initial transplantation [28, 32].
Taken together, the existing evidence show that graft
survival rate gradually decreases after 20 years post-PK.
An average best-corrected visual acuity (BCVA) in
logarithm of the minimum angle of resolution (Log-
MAR) at preoperation, 10, 20, and 25 years after sur-
gery of 1.54 ± 0.68, 0.06 ± 0.22, 0.03 ± 0.17, and 0.14 ±
0.42, respectively, have been reported [28]. Best
spectacle-corrected visual acuity (BSCVA) of 0.14 ±
0.11 LogMAR has been reported with a mean period
of 33.5 months, while a BSCVA of 20/40 or better
with a mean follow-up of 14 years was observed in
73.2 % of patients [31, 32].
An open angle glaucoma rate of 5.4 % with a mean
follow-up of 14 years has also been reported [32].
Claesson et al. reported a poorer survival and worse
visual outcome of regrafts compared with first grafts in
patients where the original indication was keratoconus:
the failure rate was three times higher with regrafts and
the observed visual acuity with preferred correction
was ≥ 0.5 in 69 % of first grafts while only 55 % of
regrafts achieved that level [33].
Deep lamellar anterior keratoplasty in
keratoconus
The goal of deep lamellar anterior keratoplasty in ker-
atoconus is to achieve a depth of dissection as close
as possible to DM. There are various ways to create a
plane of separation between DM and the deep stro-
mal layers mainly through variations of the two basic
strategies: the Anwar big bubble method and the
Melles manual dissection.
Fig. 3 Graft-host junction alignment after suturing. Normal appearance
of the graft-host junction with correct aligning of Bowman’s layer of the
donor and host corneas, with needle passed at a 90 % depth on both
sides (a). If care is not taken in cases of a thin recipient cornea, steps will
remain at the graft-host junction, leaving an irregular astigmatism and
exposed sutures that need to be replaced (b). To avoid this, a partial
thickness bite (50–70 % depth) should be performed at the donor
side (c)
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Surgical techniques
1. The big bubble method
Anwar based the big bubble method on a discovery
in 1998 that intrastromal injection of balanced salt
solution (BSS) was often effective at establishing
cleavage plane just above DM [34]. This takes advan-
tage of the loose adhesion between DM and the pos-
terior stroma. Anwar and Teichman later described
the current big bubble procedure in 2002 using air
instead of BSS [14].
After a partial trephination of 70–80 % of the corneal
stroma, pneumatic pressure is used to detach DM by
injecting air into the deep stroma with a 30G needle.
The air injected into the stroma produces a dome-
shaped detachment of DM that is seen under the surgi-
cal microscope as a ring, which signifies that the big
bubble has been formed. The stromal tissue above the
DM plane is removed with spatula and scissors, making
sure to first exchange the air in the supradescemetic
plane with viscoelastic to avoid inadvertently puncturing
the DM. When all of the stromal tissue is successfully
removed, the DM exposed should be characteristically
smooth (Fig. 4).
2. Melles manual method
This technique is based on the air-endothelium inter-
face [13]. First, the anterior chamber is filled with air.
Then, using a series of curved spatulas through a scleral
pocket, the stroma is carefully dissected away from the
underlying DM. The difference in refractive index
between air and corneal tissue creates a reflex of the sur-
gical spatulas, and the distance between the instrument
and reflex is used to judge the amount of remaining
cornea. Viscoelastic is injected through the scleral inci-
sion into the stromal pocket. Once the desired plane is
reached, the superficial stroma is removed using tre-
phine and lamellar dissection (Fig. 5).
Over the years, there have been many variations to
the standard technique. Lamellar dissection can be
made with a diamond knife, nylon wire, microkera-
tome [35] or femtosecond laser. To help in guiding
the dissection plane, trypan blue, ultrasound pachy-
metry [36] or real time optical coherence tomography
[37] (OCT) has been used. Partharsathy et al. describe
a “small bubble” technique for confirming the pres-
ence of the big bubble [38].
For corneas with extreme peripheral thinning, a modi-
fied procedure has been proposed dubbed “tuck-in
lamellar keratoplasty” [39, 40]. In this technique, the
central anterior stromal disc is removed and a centrifu-
gal lamellar dissection is performed using a knife to
create a peripheral intrastromal pocket extending
0.5 mm beyond the limbus. The donor cornea is pre-
pared in such a way that it has a central full thickness
graft with a peripheral partial thickness flange. The
edges of a large anterior lamellar graft are tucked in
below to add extra thickness.
Fig. 4 DALK Big Bubble Technique. After a partial trephination of 70–80 % of the corneal stroma 30 G needle (a). Once the air is injected, it produces a
dome-shaped detachment of the DM that is seen under the surgical microscope as a ring meaning that the big bubble has been formed (b). A lamellar
dissection with a Crescent blade of the anterior stroma is then performed (c) followed by the removal of the stromal tissue above the DM plane with
spatula and scissors (d), making sure to first exchange the air in the supradescemetic plane with viscoelastic to avoid puncturing DM inadvertently. When
all of the stromal tissue is successfully removed, the DM exposed is characteristically smooth (e), and the donor cornea without its DM and endothelium is
then sutured with the preferred suture technique (f)
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Outcomes
Most studies have found equivalent visual and refractive
results between PK and DALK, although 20/20 vision
seems more likely after PK [16, 41], provided that stro-
mal dissection reaches the level or close to the DM [16,
41–46]. For instance, in a recent study consisting
Australian patients, which included 73 consecutive pa-
tients with keratoconus, the mean BCVA was not signifi-
cantly different for DALK (0.14 logMAR, SD 0.2) versus
PK (0.05 logMAR, SD 0.11) [16, 41]. A review of pub-
lished literature that included 11 comparative studies on
DALK and PK found that visual and refractive outcomes
were comparable if the residual bed thickness in DALK
cases were between 25 and 65 μm [4].
In studies where the visual outcomes of DALK
where inferior to PK [47], the dissection plane was
“pre-descemetic” and the incomplete stromal dissec-
tion and the not fully baring of the DM had a nega-
tive impact on the results [47]. The problem seems to
be related to the depth of the undissected stromal
bed rather than to its smoothness as pre-descemetic
DALKs performed by laser ablation did not outper-
form those dissected manually.
The recently published Australian graft registry data
compared the outcomes of PKs and DALKs performed
for keratoconus over the same period of time and found
that overall, both graft survival and visual outcomes
were superior for PK. In a recent study from the UK,
Jones et al. compared the outcomes after PK and DALK
for keratoconus [16]. The risk of graft failure for DALK
was almost twice that for PK. In day-to-day clinical
practice, visual outcomes with DALK although compar-
able with PK, may be slightly inferior or less predictable
compared with PK, given surgical inexperience, and
unpredictable issues with respect to residual stromal
thickness and DM folds. Nonetheless, elimination of risk
of endothelial rejection compensates for this difference.
Lastly, one of the important advantages of DALK is a
lower rate of endothelial loss compared with PK. The re-
ported endothelial cell loss is as high as 34.6 % after PK,
whereas for after DALK, cell loss was only 13.9 % [48].
Use of femtosecond laser in corneal graft for keratoconus
In the last decade, the femtosecond laser is one of the
most important innovations in corneal transplant sur-
gery for keratoconus. The laser allows the surgeon to
focus the laser energy at a particular depth and then rap-
idly cut the tissue at that depth without causing any add-
itional injury to the surrounding tissue. This permits
doing lamellar dissection with high precision and also
allows the surgeon to pattern these cuts into shapes
(often referred to as mushroom or zig zag) creating a
highly precise incision resulting in a perfect match of
the donor tissue and the host tissue and a stronger junc-
tion and quicker visual recovery [49] (Fig. 6).
Complications
Allograft reactions are less frequent in DALK than in PK
and less likely to result in graft failure if correct treat-
ment is administered. Subepithelial and stromal rejection
after DALK has been reported to be in the range of 3–
14.3 % whereas in PK, it ranges from 13 to 31 % in the
Fig. 5 DALK Melles Technique. First, the anterior chamber is filled with air and a partial trephination of 70 % of the corneal stroma is performed (a).
Then, using a series of curved spatulas through a scleral pocket, the stroma is carefully dissected away from the underlying DM (b). The difference in
refractive index between air and corneal tissue creates a reflex of the surgical spatulas, and the distance between the instrument and reflex is used to
judge the amount of remaining underlying tissue (B, arrows). Viscoelastic is injected through the scleral incision into the stromal pocket and the
dissection can be completed through the trephination edge (c). Once completed, the superficial stroma is removed (d), the DM exposed e, and
the donor cornea sutured (f)
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first 3 years after surgery [2]. Endothelial rejection is not
an issue in DALK.
Increases in intraocular pressure (IOP) following
DALK has been reported in 1.3 % of operated eyes,
compared with 42 % of eyes after PK [48]. Develop-
ment of glaucoma may also be up to 40 % less than
PK [50]; it is attributed to the lower steroid require-
ment of DALK [51].
Urretz-Zavalia Syndrome was first reported following
PK in keratoconus. It causes fixed, dilated pupil with iris
atrophy that is a rare entity following DALK [52].
There are also a few complications that are unique to
DALK and the presence of a donor-host interface. One
of the major problems with DALKs is intraoperative
DM perforation, which may occur in 0–50 % of the
eyes [2], which has also been described to occur weeks
after an uneventful surgery [53]. Surgeon’s inexperi-
ence, corneal scarring near the DM, and advanced ecta-
sias with corneal thickness less than 250 μm increase
this risk [54, 55]. Depending on the size of the perfor-
ation, conversion to PK may be required to avoid
double anterior chamber and persistent corneal edema,
especially when the rupture leads to the collapse of the
anterior chamber (macroperforation). Incidence of
pseudo anterior chamber or double anterior chamber is
in the range of 1 % [56]. It can occur because of reten-
tion of fluid secondary to breaks in the DM or because
of incomplete removal of viscoelastic in the interface
[57]. Large pseudo chambers must be managed surgi-
cally by drainage of the fluid and anterior chamber
injection of air or gas [58], while small pseudo cham-
bers normally end up resolving spontaneously [59]. The
presence of DM folds caused by a mismatch between
donor button and the recipient bed is usually transient
and would disappear over time, but interface wrinkling
when central and persistent may affect quality of vision
[60]. Occasionally, an eye with an anatomically correct
DALK may require a secondary reoperation to inter-
face haze and poor visual acuity, usually stemming
from incomplete or pre-descemetic stromal dissection
[2]. Interface keratitis is a serious complication of
DALK and its caused mainly by Candida [61], but
Klebsiella pneumonia [62] and nontuberculous myco-
bacteria [63] have also been isolated in several cases.
Conservative treatment is usually unsuccessful and
most cases need a therapeutic PK [61]. Interface
vascularization can occur because of inflammatory,
infective, and traumatic episodes which can be treated
with bevacizumab injection [64].
Keratoconus recurrence after corneal
transplantation
We have already discussed the beneficial long-term re-
sults of the different options of corneal grafting for kera-
toconus. de Toledo et al. observed a progressive increase
of keratometric astigmatism in 70 % of their cases from
10 years after suture removal, following an initial phase
of refractive stability during the first 7 years after PK for
keratoconus (4.05 ± 2.29 D 1 year after suture removal,
3.90 ± 2.28 D at year 3, 4.03 ± 2.49 D at year 5, 4.39 ±
2.48 D at year 7, 5.48 ± 3.11 D at year 10, 6.43 ± 4.11 D
at year 15, 7.28 ± 4.21 D at year 20, and 7.25 ± 4.27 D at
year 25), suggesting that a late recurrence of the disease
may occur with an increasing risk over time [17]. Actu-
ally, a 20 year post-PK probability of 10 % have been
reported previously, with a mean time to recurrence of
Fig. 6 Femtosecond laser assisted penetrating keratoplasty with a “Zig-Zag” edge profile (a, b: courtesy of Abbott Medical Optics, USA). Postoperative
clinical picture (c) and an anterior segment OCT capture (d) where it is possible to appreciate the zig-zag edge profile at the host-donor interface with
a perfect coalescence of the edges
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17.9–21.9 years. Given the younger age at which kera-
toconus patients undergo corneal transplantation,
these long-term findings should be explained to pa-
tients and incorporated into preoperative counselling
[27, 32, 65] (Fig. 7).
It is well known how other corneal stromal dystro-
phies such as granular or lattice dystrophy tend to recur
into the donor cornea due to either colonization of the
new stroma by the abnormal host keratocytes or epithe-
lial secretion in the early stages. In keratoconus, this
host keratocyte invasion has not been well proven to be
the main etiology for the post graft recurrent ectasia,
but is likely to be related to the early keratoconic
changes observed in the histology of explanted donor
buttons after regrafting [65–67]. Post-graft ectasia is
often preceded by thinning of the recipient stroma at
the graft-host junction, so disease progression at the
host stroma is likely to be the underlying reason for
these cases of recurrent ectasia and progressive astigma-
tism [17, 65]. In such cases, a mean keratometric sphere
and cylinder increase of 4D and 3D, respectively, be-
tween final suture removal and diagnosis can be ob-
served [65].
The management of recurrent ectasia after corneal
grafting should be spectacle adjustment if low astigma-
tism levels are induced, and rigid/hybrid gas permeable
contact lenses with higher levels of astigmatism or sig-
nificant anisometropia. For more advanced cases, scleral
lenses may be considered before a surgical approach. If a
second corneal transplant is required, either a new full
thickness PK versus LK can be considered. Large grafts
are usually necessary as the whole area of thinning
should be included within the graft limits in order to
excise the whole cone to avoid a new recurrence and
also to avoid suturing through a thin recipient cornea.
As large grafts are associated with increased risk of re-
jection and glaucoma, lamellar techniques by manual
dissection of the host and donor corneal stroma are al-
ways preferable as far as the donor endothelium presents
healthy without signs of failure. If femtosecond dissec-
tion of the lamellar bed is chosen, gentian violet and
cyanoacrylate glue can be used in the area of thinning as
masking agents to minimize the risk of perforation [68].
Limbus may have to be recessed while suturing very
large grafts that sit close to the limbus in order to
avoid passing the suture through the host’s conjunc-
tiva. Recurrence after regrafting has also been re-
ported, so much so that it may require a third graft
for visual rehabilitation [65].
Keratoconus recurrence after DALK has not been de-
scribed. Very little evidence about its real incidence and
impact is currently available. Feizi et al. reported a case
where keratoconus recurred only 49 months after DALK
[69]. They suggested that the time interval from trans-
plantation to recurrence may be shorter after DALK
than after PK, but this has not been supported or con-
firmed by other authors [70]. Further studies analyzing
the long term outcomes after DALK for keratoconus is
required in order to assess its impact [68].
A glance into the future
Keratoconus is a corneal disease that primarily affects
the corneal stroma and Bowman’s layer. Current re-
search and future therapeutic directions are focusing on
the regeneration of corneal stroma by little to no inva-
sive procedures to avoid the common complications that
we still see even with LK techniques.
In the last few years, various studies have shown that
CXL may offer some promise in slowing the progression
of the disease [71, 72]. New modalities of CXL are being
explored to improve the outcomes. CXL along with
topography-guided photorefractive keratectomy (PRK) in
order to provide better visual rehabilitation in patients
with keratoconus is already being used [73]. A novel
approach to enhance riboflavin penetration is based on
iontophoresis, a non-invasive system aimed to enhance the
delivery of charged molecules into tissues using a small
electric current. It has been shown that an iontophoresis
Fig. 7 Keratoconus recurrence. Slit lamp image of the recurrence 17 years after a penetrating keratoplasty (a). Observe the severe thinning of the
recipient stroma at the graft-host junction (b)
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imbibition lasting 5 min achieves a sufficient riboflavin con-
centration in the corneal stroma for CXL treatment, with
the advantage of shortening the imbibition time while pre-
serving epithelial integrity [74]. Accelerated CXL was intro-
duced in clinical practice in order to shorten the time
required for a CXL procedure [75]. This technique is based
on the Bunsen-Roscoe law of photochemical reciprocity.
That is, the same photochemical effect can be achieved
with reducing the irradiation interval provided that the total
energy level is kept constant by a corresponding increase in
irradiation intensity. In this modality, pulsed accelerated
corneal collagen crosslinking seems to be more effective
than continuous light accelerated corneal collagen cross-
linking [76].
Melles at al. recently described a new technique
where an isolated Bowman’s layer is transplanted into a
mid-stromal manually dissected corneal pocket in pa-
tients with an advanced (Stage III-IV) keratoconus [77].
They observed a modest improvement in the maximum
keratometry and BSCVA, but an unchanged best con-
tact lens corrected visual acuity (BCLVA). This is a new
and interesting approach that could have its indication
for those advanced keratoconus unsuitable for corneal
collagen crosslinking or intracorneal ring segments and
intolerant to contact lenses, but without visually signifi-
cant corneal scars and therefore good BCLVA. In such
cases, Bowman’s transplant could avoid or postpone the
necessity of keratoplasty if the mild observed corneal
flattening enables continued contact lens wear and the
cone is stabilized (as it has been reported to happen,
but only with a sample of 20 eyes and a short mean
follow-up of 21 months). Further research by alterna-
tive authors with a larger sample and longer follow up
is needed before introducing this technique into routine
clinical practice.
As discussed, Bowman’s transplantation could have
some benefits in cases of advanced keratoconus, but
even if these results are finally confirmed by other
authors, they offer a mild improvement to these patients
without a significant functional/anatomical rehabilita-
tion. Thus, further techniques may focus on attempting
the subtotal regeneration or substitution of the corneal
stroma in order to achieve better results. Different types
of stem cells have been used in various ways by several
research groups in order to find the optimal procedure
to regenerate the human corneal stroma: Corneal
Stromal Stem Cells (CSSC), Bone Marrow Mesenchymal
Stem Cells (BM-MSCs), Adipose Derived Adult Mesen-
chymal Stem Cells (ADASCs), Umbilical Cord Mesen-
chymal Stem Cells (UCMSCs), and Embryonic Stem
Cells (ESCs) [78]. These approaches can be classified
into four techniques:
A. Intrastromal injection of stem cells alone:
Direct injection of stem cells inside the corneal stroma
has been assayed in vivo in some studies, demonstrating
the differentiation of the stem cells into adult kerato-
cytes without signs of immune rejection. Our group
showed the production of human extracellular matrix
(ECM) when human ADASCs (h-ADASC) were trans-
planted inside the rabbit cornea [79]. Du et al. reported
a restoration of the corneal transparency and thickness
in lumican null mice (thin corneas, haze and disruption
of normal stromal organization) 3 months after the
intrastromal transplant of human CSSCs. They also con-
firmed that human keratan sulphate was deposited in
the mouse stroma and the host collagen lamellae were
reorganized, which led to the conclusion that delivery of
h-CSSCs to scarred human stroma may alleviate corneal
scars without requiring surgery [80]. Very similar find-
ings were reported by Liu et al. using human umbilical
mesenchymal stem cells (UMSCs) in the same animal
model [81]. Recently, Thomas et al. found that in a mice
model for mucopolysaccharidosis, transplanted human
UMSC participate both in extracellular glycosaminogly-
cans (GAG) turnover and enable host keratocytes to
catabolize accumulated GAG products [82]. In our ex-
perience, the production of human ECM by implanted
mesenchymal stem cells occurs, but not quantitatively
enough to be able to restore the thickness of a diseased
human cornea. However, the direct injection of stem
cells may provide a promising treatment for corneal dys-
trophies including keratoconus, via the regulation of
abnormal host keratocyte collagen production to enable
collagen microstructure reorganization and corneal scar-
ring modulation.
B) Intrastromal implantation of stem cells together
with a biodegradable scaffold:
In order to enhance the growth and development of
the stem cells injected into the corneal stroma, trans-
plantation with biodegradable synthetic extracellular
matrixes (ECMs) has been performed. Espandar et al.
injected h-ADASCs with a semisolid hyaluronic acid
hydrogel into the rabbit corneal stroma. They report bet-
ter survival and keratocyte differentiation of the h-
ADASCs when compared with injection alone [83]. Ma
et al. used rabbit adipose-derived stem cells (ADSCs)
with a polylactic-coglycolic (PLGA) biodegradable scaf-
fold in a rabbit model of stromal injury and observed
newly formed tissue with successful collagen remodeling
and less stromal scarring [84]. Initial data show that
these scaffolds could enhance stem cell effects over cor-
neal stroma, although more research is required.
C) Intrastromal implantation of stem cells with a non-
biodegradable scaffold:
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At the present moment, no clinically viable human
corneal equivalents have been produced by tissue engin-
eering methods. The major obstacle to the production of
a successfully engineered cornea is the difficulty with re-
producing (or at least simulating) the stromal architec-
ture. The majority of stromal analogs for tissue
engineered corneas have been created by seeding human
corneal stromal cells into collagen-based scaffoldings,
which are apparently designed to be remodeled (see
Ruberti et al. 2008 for a general review of corneal tissue
engineering) [85]. The major drawback of these analogs
is their lack of strength, thus unable to restore the
normal mechanical properties of the cornea. New and
improved biomaterials compatible with human corneas
and with enhanced structural support have been devel-
oped leading to advanced scaffolds that can be used to
engineer an artificial cornea (keratoprosthesis) [78]. The
combination of these scaffolds with cells can generate
promising corneal stroma equivalents, and some studies
have already been published that use mainly corneal cell
lines providing positive results regarding adhesion and
cellular survival in vitro [86]. Our opinion is that stem
cells do not differentiate properly into keratocytes in
the presence of these synthetic biomaterials. Doing so
Fig. 8 Reconstruction of corneal stroma. a: Hematoxylin-eosin staining of a rabbit cornea with an implanted graft of decellularized human corneal stroma
with h-ADASC colonization: hypocellular band of ECM without vessels or any inflammatory sign (magnification 200X); b: Human cells labeled with CM-DiI
around and inside the implant that express (c) human keratocan (human adult keratocyte specific marker; magnification 400X), confirming the presence of
living human cells inside the corneal stroma and their differentiation into human keratocytes (arrows); d: Phase-contrast photomicrographs showing a
morphologically unaltered corneal stroma (magnification 400X); e: The graft remains totally transparent after 12 weeks of follow-up (magnification 2X)
(arrows point to the slightly visible edge of the graft). Abbreviations: Epi: epithelium; Str: stroma; Lam: Lamina
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makes them lose their potential benefits and not re-
solve the major drawbacks with such substitutes: their
relatively high extrusion rate and lack of complete
transparency [87].
D) Intrastromal implantation of stem cells with a
decellularized corneal stromal scaffold:
The complex structure of the corneal stroma has not
yet been replicated, and there are well-known drawbacks
to the use of synthetic scaffold-based designs. Recently,
several corneal decellularization techniques have been
described, which provide an acellular corneal ECM [88].
These scaffolds have gained attention in the last few
years as they provide a more natural environment for
the growth and differentiation of cells when compared
with synthetic scaffolds. In addition, components of the
ECM are generally conserved among species and are tol-
erated well even by xenogeneic recipients. Keratocytes
are essential for remodeling the corneal stroma and for
normal epithelial physiology [89]. This highlights the
importance of transplanting a cellular substitute together
with the structural support (acellular ECM) to under-
take these critical functions in corneal homeostasis. To
the best of our knowledge, all attempts to repopulate
decellularized corneal scaffolds have used corneal cells
[90–92], but these cells have major drawbacks that pre-
clude their autologous use in clinical practice (damage
of the donor tissue, lack of cells and inefficient cell sub-
cultures), thus the efforts to find an extraocular source
of autologous cells. In a recent study by our group, we
showed the perfect biointegration of human decellular-
ized corneal stromal sheets (100 μm thickness) with
and without h-ADASC colonization inside the rabbit
cornea in vivo (Fig. 8a and b), without observing any
rejection response despite the graft being xenogeneic
[93]. We also demonstrated the differentiation of h-
ADASCs into functional keratocytes inside these
implants in vivo, which then achieved their proper bio-
functionalization (Fig. 8c). In our opinion, the trans-
plant of stem cells together with decellularized corneal
ECM would be the best technique to effectively re-
store the thickness of a diseased human cornea such
as that in keratoconus. Through this technique and
using extraocular mesenchymal stem cells from pa-
tients, it is possible to transform allergenic grafts into
functional autologous grafts, theoretically avoiding the
risk of rejection.
Conclusion
Treatment of keratoconus has experienced great ad-
vances in the last two decades. From being limited only
to rigid gas permeable contact lens wear and PK for the
most advanced cases, to having different therapeutic
alternatives currently to treat not only the cone and
postpone/avoid the necessity of a corneal transplant, but
also being able to halt the progression of the disease
with a very high rate of efficacy and safety. Also, the ad-
vances in refractive surgery including surface corneal ab-
lation treatments and phakic intraocular lenses have
allowed a better management and visual rehabilitation of
these patients after a corneal transplant is required, be-
ing able to achieve, in many cases, a 20/20 unaided vi-
sion. The future expected advances in transepithelial
crosslinking, nanotechnology, and regenerative medicine
predicts an exciting future in this field and we will be
looking forward to updating these guidelines.
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